Brief: Cytrx to present new clinical data on its cancer drug
20/04/2016 14:00
April 20 (Reuters) - Cytrx Corp CYTR.O
* Cytrx to present updated aldoxorubicin clinical trial data
at the American Society of Clinical Oncology Annual Meeting in
June 2016
Source text for Eikon: ID:nPn7K2mSKa
Further company coverage: CYTR.O
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C